314129 Logo (WIPO, 09/30/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark 314129 was filed as Figurative mark on 09/30/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Stars, comets #Parts of the human body, skeletons, skulls #Colours #One star #Hearts #Other parts of the human body, DNA band, cells, brains, sperms, hair roots (also 2.9.12) #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1633789 |
| Register number | 314129 |
| Countries | 
|
| Base trademark |
No. 314129,
July 5, 2021
|
| Application date | September 30, 2021 |
| Expiration date | September 30, 2031 |
Trademark owner
Campus-Vienna-Biocenter 5,
Helmut-Qualtinger-Gasse 6
AT
Helmut-Qualtinger-Gasse 6
AT
Trademark representatives
Riemergasse 14
A-1010 Wien
AT
goods and services
01
Chemical, biochemical and biotechnological products used in
industry and science; reagents (other than for medical or
veterinary purposes) for purifying and analyzing samples for
use in the fields of molecular biology, chemistry,
biochemistry, drug discovery, pharmacology, toxicology,
molecular pathology, disease research, genomics and
proteomics; chemical, biochemical and biotechnological
substances for industrial and scientific purposes, in
particular for molecular biological applications for DNA
(deoxyribonucleic acid) treatment, RNA (ribonucleic acid)
treatment and protein treatment; chemical, biochemical and
biotechnological preparations for diagnostic and scientific
purposes, laboratory reagents and diagnostic reagents, all
the aforesaid goods, in particular for the treatment and
purification of samples of human, animal and plant cells and
tissues and samples of microorganisms and of extracts
therefrom (not for medical or veterinary purposes);
diagnostic reagents for in vitro use in clinical chemistry;
enzymes, not for medical or veterinary purposes, in
particular for use in kits and for use in carrying out DNA
labeling, DNA replication, DNA analysis or RNA labeling, RNA
replication, RNA analysis and for enzyme preparations
05
Veterinary products; pharmaceutical preparations, namely,
nucleic acid molecules for medical and veterinary purposes,
for use in determining genotypes, profiling biopolymer,
detecting disease, determining disease progression, and
determining responses to drugs; diagnostic reagents for
medical use in diagnosing inflammation, infection, central
nervous system diseases, cardiovascular, neurological,
endocrine, autoimmune and genetic diseases, and cancer,
comprised of reagents, processing chemicals and nucleic acid
molecules; medical diagnostic test kits for the detection of
pathogens in the environment; clinical and diagnostic
reagents and preparations for medical and veterinary
purposes; medical diagnostic test kits to identify, quantify
and analyze dna or rna; reagents and enzymes for performing
dna or rna analyzes for medical purposes
09
Scientific apparatus, instruments and devices, in particular
for research and diagnostic purposes; software, in
particular software for data analysis, software for the
analysis of bioinformatic data, sequence data on fragmented
sequence information, for pcr analysis and for next
generation sequencing; chromatographic columns for
scientific or laboratory use; all the aforesaid goods for
industrial and scientific purposes, in particular for
molecular biological purposes for DNA (deoxyribonucleic
acid) treatment, RNA (ribonucleic acid) treatment and
protein treatment or for the purification of these
molecules, and for reagent kits for industrial and
scientific purposes, in particular for DNA (deoxyribonucleic
acid) treatment, RNA (ribonucleic acid) treatment and
protein treatment or purification of these molecules;
laboratory equipment, in particular automated microfluidic
and macrofluidic devices for the isolation, preparation,
marking, replication or screening of genetic material or RNA
or proteins
42
Services in connection with scientific research and
development, in particular in the field of research,
development and diagnostics, and design services in this
field; scientific and technological services, namely
scientific analysis in the field of research, development
and diagnostics relating to genomics, transcriptomics,
proteomics and genetic engineering; design of pharmaceutical
and medical diagnostic products and biochemical and
biotechnological preparations relating to genomics,
transcriptomics, proteomics and genetic engineering;
scientific and technological services, namely scientific
research, development, diagnostics and analysis in the field
of diagnostic chemicals and reagents, sorting of
nucleotides, separation processes and purification
processes, chemical screening analyzes and conducting
diagnostic, forensic and genetic-medical tests for others;
scientific research and development for others in the field
of diagnostic chemical agents and reagents for use as
diagnostic, therapeutic preparations and chemical screening
and diagnostics for others; conducting quality control tests
and quality control of scientific analyzes relating to
nucleic acids; scientific analyzes in relation to nucleic
acids, in particular for detection purposes; scientific and
technological services, in particular scientific and
technological services for the treatment of nucleic acids
and proteins, in particular separation, purification,
isolation, labeling and amplification of the aforesaid
molecules; development of software, in particular
development of software for data analysis, for the analysis
of bioinformatic data, sequence data and fragmented sequence
information, and development of software for pcr analysis
and next generation sequencing; scientific analyzes of
bioinformatic data, sequence data and fragmented sequence
information, especially in the context of next generation
sequencing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| June 10, 2023 | 2023/24 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 25, 2023 | 2023/22 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 14, 2023 | 2023/16 Gaz | CA | Rejection |
| February 1, 2023 | 2023/5 Gaz | KR | Rejection |
| December 21, 2022 | 2022/51 Gaz | NO | Rejection |
| November 17, 2022 | 2022/47 Gaz | BR | Rejection |
| November 4, 2022 | 2022/45 Gaz | CH | Rejection |
| October 27, 2022 | 2022/43 Gaz | JP | Rejection |
| October 10, 2022 | 2022/41 Gaz | IN | Rejection |
| July 16, 2022 | 2022/29 Gaz | US | Rejection |
| May 6, 2022 | 2022/19 Gaz | EM | Rejection |
| April 20, 2022 | 2022/16 Gaz | CN | Rejection |
| March 21, 2022 | 2022/12 Gaz | GB | Rejection |
| March 21, 2022 | 2022/12 Gaz | RU | Rejection |
| March 16, 2022 | 2022/11 Gaz | AU | Rejection |
| September 30, 2021 | 2021/48 Gaz | AT | Registration |
ID: 141633789